DZ2607A1 - Procédé pour la synthése de dérivés de quinoléine pharmaceutiquement actifs. - Google Patents
Procédé pour la synthése de dérivés de quinoléine pharmaceutiquement actifs.Info
- Publication number
- DZ2607A1 DZ2607A1 DZ980217A DZ980217A DZ2607A1 DZ 2607 A1 DZ2607 A1 DZ 2607A1 DZ 980217 A DZ980217 A DZ 980217A DZ 980217 A DZ980217 A DZ 980217A DZ 2607 A1 DZ2607 A1 DZ 2607A1
- Authority
- DZ
- Algeria
- Prior art keywords
- synthesis
- pharmaceutically active
- quinoline derivatives
- active quinoline
- derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/36—Sulfur atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
- C07D209/32—Oxygen atoms
- C07D209/38—Oxygen atoms in positions 2 and 3, e.g. isatin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/38—Nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
- C07D215/50—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 4
- C07D215/52—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 4 with aryl radicals attached in position 2
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Pulmonology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Quinoline Compounds (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US5930397P | 1997-09-17 | 1997-09-17 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DZ2607A1 true DZ2607A1 (fr) | 2003-03-01 |
Family
ID=22022126
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DZ980217A DZ2607A1 (fr) | 1997-09-17 | 1998-09-14 | Procédé pour la synthése de dérivés de quinoléine pharmaceutiquement actifs. |
Country Status (32)
| Country | Link |
|---|---|
| US (6) | US6335448B1 (fr) |
| EP (1) | EP1017676B1 (fr) |
| JP (1) | JP2001516744A (fr) |
| KR (1) | KR20010024031A (fr) |
| CN (1) | CN1125815C (fr) |
| AP (1) | AP1201A (fr) |
| AR (1) | AR015445A1 (fr) |
| AT (1) | ATE353879T1 (fr) |
| AU (1) | AU744538B2 (fr) |
| BG (1) | BG104243A (fr) |
| BR (1) | BR9812085A (fr) |
| CA (1) | CA2303026A1 (fr) |
| DE (1) | DE69837100T2 (fr) |
| DZ (1) | DZ2607A1 (fr) |
| EA (1) | EA002633B1 (fr) |
| ES (1) | ES2283072T3 (fr) |
| HU (1) | HUP0004855A3 (fr) |
| ID (1) | ID24140A (fr) |
| IL (1) | IL134991A0 (fr) |
| MA (1) | MA24644A1 (fr) |
| MY (1) | MY120237A (fr) |
| NO (1) | NO314303B1 (fr) |
| NZ (1) | NZ503307A (fr) |
| OA (1) | OA11340A (fr) |
| PE (1) | PE129299A1 (fr) |
| PL (1) | PL339340A1 (fr) |
| SK (1) | SK3672000A3 (fr) |
| TR (1) | TR200000720T2 (fr) |
| TW (1) | TW509678B (fr) |
| UY (2) | UY25174A1 (fr) |
| WO (1) | WO1999014196A1 (fr) |
| ZA (1) | ZA988455B (fr) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AP1201A (en) * | 1997-09-17 | 2003-09-01 | Smithkline Beecham Corp | Method for the synthesis of quinoline derivatives. |
| JP2002540203A (ja) | 1999-03-29 | 2002-11-26 | ニューロゲン コーポレイション | Ｎｋ−３および／またはｇａｂａ（ａ）受容体リガンドとしての４−置換キノリン誘導体 |
| EP1716137A1 (fr) | 2004-02-04 | 2006-11-02 | Pfizer Products Incorporated | Composes de quinoline substitues |
| KR20080016591A (ko) * | 2005-06-03 | 2008-02-21 | 아스트라제네카 아베 | Ｎｋ3 길항제로서의 퀴놀린 유도체 |
| EP1919871A4 (fr) * | 2005-08-02 | 2010-08-18 | Glaxosmithkline Llc | Procédé pour la synthèse de dérivés de la quinoline |
| JP2009504642A (ja) * | 2005-08-11 | 2009-02-05 | アストラゼネカ・アクチエボラーグ | Ｎｋ−３受容体の調節剤としてのオキソピリジルキノリンアミド |
| CN101268052A (zh) * | 2005-09-21 | 2008-09-17 | 阿斯利康(瑞典)有限公司 | 作为nk-3受体配体的n-氧代-杂环和n-氧代-烷基喹啉-4-甲酰胺 |
| AR057130A1 (es) * | 2005-09-21 | 2007-11-14 | Astrazeneca Ab | Quinolinas de alquilsulfoxido y una composicion farmaceutica |
| WO2007086799A1 (fr) * | 2006-01-27 | 2007-08-02 | Astrazeneca Ab | Quinoléines substituées par un amide |
| CN102702099A (zh) * | 2012-06-21 | 2012-10-03 | 江苏恩华药业股份有限公司 | (s)-3-羟基-2-苯基-n-(1-苯基丙基)喹啉-4-甲酰胺的制备方法 |
| CN102924375B (zh) * | 2012-06-21 | 2015-02-18 | 江苏恩华药业股份有限公司 | Talnetant中间体及其制备方法和应用 |
| CN103214416A (zh) * | 2013-04-26 | 2013-07-24 | 扬州大学 | 一种合成多取代喹啉类化合物的方法 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2776290A (en) * | 1957-01-01 | Hydroxy cevchoninates and carboxylic | ||
| ATE246677T1 (de) * | 1994-05-27 | 2003-08-15 | Smithkline Beecham Farma | Chinolinderivate als tachykinin nk3 rezeptor antagonisten |
| US5627193A (en) * | 1995-02-09 | 1997-05-06 | Mitsui Toatsu Chemicals, Inc. | Quinoline-4-carbonylguanidine derivatives, process for producing the same and pharmaceutical preparations containing the compounds |
| AP1201A (en) * | 1997-09-17 | 2003-09-01 | Smithkline Beecham Corp | Method for the synthesis of quinoline derivatives. |
-
1998
- 1998-05-08 AP APAP/P/2000/001767A patent/AP1201A/en active
- 1998-09-08 UY UY25174A patent/UY25174A1/es not_active Application Discontinuation
- 1998-09-08 MA MA25246A patent/MA24644A1/fr unknown
- 1998-09-11 PE PE1998000868A patent/PE129299A1/es not_active Application Discontinuation
- 1998-09-14 DZ DZ980217A patent/DZ2607A1/fr active
- 1998-09-15 MY MYPI98004207A patent/MY120237A/en unknown
- 1998-09-16 ZA ZA988455A patent/ZA988455B/xx unknown
- 1998-09-16 AR ARP980104603A patent/AR015445A1/es not_active Application Discontinuation
- 1998-09-17 TR TR2000/00720T patent/TR200000720T2/xx unknown
- 1998-09-17 US US09/508,358 patent/US6335448B1/en not_active Expired - Fee Related
- 1998-09-17 PL PL98339340A patent/PL339340A1/xx unknown
- 1998-09-17 IL IL13499198A patent/IL134991A0/xx unknown
- 1998-09-17 CN CN98810978A patent/CN1125815C/zh not_active Expired - Fee Related
- 1998-09-17 EP EP98947099A patent/EP1017676B1/fr not_active Expired - Lifetime
- 1998-09-17 HU HU0004855A patent/HUP0004855A3/hu unknown
- 1998-09-17 EA EA200000322A patent/EA002633B1/ru not_active IP Right Cessation
- 1998-09-17 AU AU93958/98A patent/AU744538B2/en not_active Ceased
- 1998-09-17 WO PCT/US1998/019434 patent/WO1999014196A1/fr active IP Right Grant
- 1998-09-17 ID IDW20000498A patent/ID24140A/id unknown
- 1998-09-17 BR BR9812085-9A patent/BR9812085A/pt not_active IP Right Cessation
- 1998-09-17 KR KR1020007002766A patent/KR20010024031A/ko not_active Application Discontinuation
- 1998-09-17 DE DE69837100T patent/DE69837100T2/de not_active Expired - Lifetime
- 1998-09-17 JP JP2000511747A patent/JP2001516744A/ja active Pending
- 1998-09-17 ES ES98947099T patent/ES2283072T3/es not_active Expired - Lifetime
- 1998-09-17 CA CA002303026A patent/CA2303026A1/fr not_active Abandoned
- 1998-09-17 SK SK367-2000A patent/SK3672000A3/sk unknown
- 1998-09-17 AT AT98947099T patent/ATE353879T1/de not_active IP Right Cessation
- 1998-09-17 NZ NZ503307A patent/NZ503307A/en unknown
- 1998-09-29 TW TW087114858A patent/TW509678B/zh not_active IP Right Cessation
-
1999
- 1999-02-26 UY UY25407A patent/UY25407A1/es unknown
-
2000
- 2000-03-15 BG BG104243A patent/BG104243A/xx unknown
- 2000-03-16 OA OA1200000078A patent/OA11340A/en unknown
- 2000-03-16 NO NO20001387A patent/NO314303B1/no not_active IP Right Cessation
-
2001
- 2001-10-17 US US09/981,185 patent/US20020038029A1/en not_active Abandoned
-
2002
- 2002-06-17 US US10/174,458 patent/US20020173657A1/en not_active Abandoned
-
2003
- 2003-05-20 US US10/441,708 patent/US20040049031A1/en not_active Abandoned
-
2005
- 2005-03-30 US US11/093,701 patent/US20050171152A1/en not_active Abandoned
-
2006
- 2006-04-28 US US11/413,932 patent/US20060189809A1/en not_active Abandoned
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DZ2653A1 (fr) | Procédé de préparation de dérivés de la classe destaxoïdes. | |
| DZ3079A1 (fr) | Procédé pour la préparation de 4-carboxy-amino-2-substitué-1,2,3,4 tétrahydroquinolé. | |
| DZ2247A1 (fr) | Procédé pour la préparation du sildénafil. | |
| DZ2135A1 (fr) | Procédé de préparation de mélamine pure. | |
| HK1029942A1 (en) | Prostaglandin derivatives devoid of side-effects for the treatment of glaucoma. | |
| DZ2912A1 (fr) | Procédé pour la préparation de pyrazolo Ä4,3-DÜpyrimidine-7-ones, et intermédiaires pour ce procédé. | |
| DZ2607A1 (fr) | Procédé pour la synthése de dérivés de quinoléine pharmaceutiquement actifs. | |
| DZ1946A1 (fr) | Procédé pour la préparation de supports. | |
| DZ2637A1 (fr) | Procédé de production de thiazolidinediones substituées. | |
| DZ2430A1 (fr) | Procédé pour la préparation de dérivés de thiazolidinedione substitués. | |
| FR2721598B1 (fr) | Procédé de préparation de catalyseurs d'ammoxydation. | |
| DZ2619A1 (fr) | Procédé pour la préparation d'acides 4-phényl-4-cyanocyclohexanoïques substitués. | |
| DZ3096A1 (fr) | Procédé pour la préparation de dérivés de pyrazoloÄ4,3-DÜpyrimidine-7-one-3-pyridylsulfonyle, et intermédiaires utilisés. | |
| DZ2746A1 (fr) | Nouveau procédé de préparation de la fexofénadine. | |
| DZ2423A1 (fr) | Procédé pour la préparation d'acides 4-phényl-4-cyanocyclohexanoiques substitués. | |
| DZ2757A1 (fr) | Procédé pour la préparation d'acides hydroxamiques. | |
| NO20013995D0 (no) | Fremgangsmate for fremstilling av L-sorbose | |
| FR2696745B1 (fr) | Procédé de préparation de dérivés de phényltétrazole. | |
| DZ2770A1 (fr) | Procédé de préparation de 1h-indol-3 glyoxamides substituées en position 4. | |
| NO973835D0 (no) | Fremgangsmåte for fremstilling av lorakarbefmonohydrat | |
| NO20022956D0 (no) | Fremgangsmåte for fremstilling av nitroguanidin | |
| IL138843A0 (en) | Improved process for the manufacture of n- (1-cyanoalkyl) -2-phenoxypropionamide derivatives | |
| FR2701259B1 (fr) | Procédé pour la préparation de dérivés phénylbenzamides fongicides agricoles. | |
| NO20005818L (no) | Forbedret fremgangsmåte for fremstilling av farmasöytisk verdifulle norbenzomorfan-derivater | |
| NO20013044L (no) | Fremgangsmåte for fremstilling av NG-substituerte deaza- adenosinderivater |